Steven Jon Axon
Algemeen Directeur bij Glycomine, Inc.
Oorsprong van het eerstegraads netwerk van Steven Jon Axon
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Complement Therapeutics Ltd.
Complement Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Complement Therapeutics Ltd. develops medicines that target the complement system. The British company was founded by Richard Unwin, Simon J. Clark, and Paul Bishop. The CEO is Rafiq Hasan.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Glycomine, Inc.
Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA.
6
| Holding Company | Biotechnology | 6 |
Metronet (UK) Ltd.
Metronet (UK) Ltd. Specialty TelecommunicationsCommunications Metronet (UK) Ltd. provides wireless Internet services. Its products include wireless Direct Connect, connectivity, networks, voice, network security, datacentre and cloud, and consultancy and managed services. The company was founded by James McCall on November 25, 2003 and is headquartered in Manchester, the United Kingdom.
3
| Holding Company | Specialty Telecommunications | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Steven Jon Axon via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Moco Bidco Ltd.
Moco Bidco Ltd. Financial ConglomeratesFinance Moco Bidco Ltd. operates as a holding firm. The company was founded on February 13, 2020 and is headquartered in Manchester, the United Kingdom. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Founder Consultant / Advisor Private Equity Investor | |
Pimco 2947 Bidco Ltd.
Pimco 2947 Bidco Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pimco 2947 Topco Ltd., Pimco 2947 Bidco Ltd. provides advisory services. The company is based in Manchester, UK and was founded in 2014. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management is a venture capital firm, a subsidiary of BioGeneration Holding BV and was founded in 2006. Biogeneration management is headquartered in Naarden. | Investment Managers | Private Equity Investor Private Equity Analyst | |
RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
M247 Ltd.
M247 Ltd. Information Technology ServicesTechnology Services M247 Ltd. provides internet services. The firm’s services include data and network security, scalable cloud solutions and web hosting. The company was founded in May 2000 and is headquartered in Manchester, the United Kingdom. | Information Technology Services | Chairman Director/Board Member | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Manchester Metronet Ltd.
Manchester Metronet Ltd. Financial ConglomeratesFinance Manchester Metronet Ltd. functions as an investment holding company. The company was founded on December 8, 2011 and is headquartered in Manchester, the United Kingdom. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Pimco 2947 Topco Ltd.
Pimco 2947 Topco Ltd. Miscellaneous Commercial ServicesCommercial Services Pimco 2947 Topco Ltd. is a holding British company that provides information technology connectivity and infrastructure services. The private company is based in Manchester, UK. and has subsidiaries in United Kingdom. The company was founded in 2014. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Venus Business Communications Ltd.
Venus Business Communications Ltd. Internet Software/ServicesTechnology Services Venus Business Communications Ltd. provides internet solutions to businesses. It offers fibre leased lines, data centre connectivity, and hosted voice over internet protocol services. The firm serves media and communications leased lines, leased lines for financial services, education technology, multi tenant internet, and resellers. The company was founded in 1996 and is headquartered in London, the United Kingdom. | Internet Software/Services | Director/Board Member Director/Board Member | |
Sparrow Pharmaceuticals, Inc.
Sparrow Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sparrow Pharmaceuticals, Inc. engages in pharmaceuticals industry. It develops drugs for cushing?s syndrome. The company was founded by David A. Katz and is headquartered in Portland, OR. | Pharmaceuticals: Major | Director/Board Member | |
Pembroke College Oxford | College/University | Graduate Degree | |
Ziarco Group Ltd.
Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
The British Amateur Gymnastics Association
The British Amateur Gymnastics Association Movies/EntertainmentConsumer Services The British Amateur Gymnastics Association, also known as British Gymnastics, is the national governing body for gymnastics in the UK. The non-profit company is based in Newport, UK. The British company's focus is on developing individuals with the necessary skills and expertise to safely deliver gymnastics in engaging and rewarding environments. The company achieves this through their education program and ongoing support for clubs and coaches. The company was founded in 1888. Sarah Powell has been the CEO of the company since 2021. | Movies/Entertainment | Chairman | |
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder | |
Arqiva Broadcast Parent Ltd.
Arqiva Broadcast Parent Ltd. Telecommunications EquipmentElectronic Technology Part of Arqiva Group Ltd., Arqiva Broadcast Parent Ltd. is a company that is at the heart of the broadcast and utilities sectors in the UK and abroad, providing critical data, network, and communications services. Arqiva Broadcast Parent Ltd. is based in Winchester, UK. Arqiva's affiliate distribution service utilizes their infrastructure with satellite, fiber, cloud, and internet connectivity options, enabling the launch of TV channels into new markets. | Telecommunications Equipment | Director/Board Member | |
Curzion Pharmaceuticals, Inc.
Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder | |
Rady School of Management at UC San Diego | College/University | Masters Business Admin | |
MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Avalyn Pharma, Inc.
Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Lyric Pharmaceuticals, Inc.
Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lyric Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The firm develops novel gastrointestinal therapeutics for unmet medical needs in the hospital settings. The company was founded by David Wurtman and M. Scott Harris in 2013 and is headquartered in South San Fancisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Metrion Biosciences Ltd.
Metrion Biosciences Ltd. BiotechnologyHealth Technology Metrion Biosciences Ltd. is a contract research organization that specializes in providing drug discovery services to pharmaceutical and bioscience customers. Metrion Biosciences is based in Great Abington, UK and was founded in 2015. The British company offers a range of high-quality ion channel assays on a fee-for-service or collaboration basis, including an industry-leading panel of in vitro cardiac ion channel safety assays, translational native cell and phenotypic assays for neurological and cardiotoxicity testing, and a range of other ion channel screening services such as cell line development and optimization. Andrew Southan has been the CEO of the company since 2016. | Biotechnology | Director/Board Member | |
Enterprise Therapeutics Ltd.
Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Enterprise Therapeutics Ltd. operates as a drug discovery company that engages in the research and development of therapies for the treatment of respiratory diseases. It focuses on developing therapies for chronic obstructive pulmonary diseases, cystic fibrosis, and asthma. The company was founded by John Mervyn David Store in May 2014 and is headquartered in Falmer, the United Kingdom. | Biotechnology | Chief Executive Officer | |
Charles River Discovery Research Services UK Ltd.
Charles River Discovery Research Services UK Ltd. Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services UK Ltd. provides drug discovery products and services to various pharmaceutical companies. It focuses on three areas such as kinases, G-protein coupled receptors, and ion channels. The company was founded in 1997 and is headquartered in Kent, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
FREEDOM4 GRP PLC | Specialty Telecommunications | Corporate Officer/Principal | |
Cambridge Drug Discovery Holdings Ltd.
Cambridge Drug Discovery Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Cambridge Drug Discovery Holdings Ltd. is a company that researches potential new drugs for the treatment of cancer. The company is based in Cambridge, UK. Cambridge Drug Discovery Holdings was acquired by Charles River Discovery Research Services UK Ltd., part of Charles River Laboratories International, Inc. from November 14, 2005 on June 11, 2001 for $38 million. The British company was founded by Barry Kenny, Jonathan Mark Treherne. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Leeds | College/University | Doctorate Degree | |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Founder | |
Onyx Group Ltd.
Onyx Group Ltd. Information Technology ServicesTechnology Services The Onyx Group Ltd. provides Information Technology (IT) infrastructure and support services. It offers cloud backup, cloud hosting, managed hosting, colocation, connectivity, workplace recovery, IT support, and security solutions. The company was founded on January 21, 2006 and is headquartered in Reading, the United Kingdom. | Information Technology Services | Director of Finance/CFO | |
UK Web.Solutions Direct Ltd
UK Web.Solutions Direct Ltd Information Technology ServicesTechnology Services UK Web.Solutions Direct Ltd provides web hosting services. The firm provides reseller hosting, managed VPS, managed servers, domain names and SSL certificates. The company was incorporated on January 06, 2006 and is headquartered in Manchester, the United Kingdom. | Information Technology Services | Director/Board Member | |
NewAmsterdam Pharma BV
NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Chief Operating Officer | |
Syracuse University | College/University | Undergraduate Degree | |
University Of Dundee | College/University | Doctorate Degree | |
Novo Ventures 1 A/S
Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor | |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
Forbion Capital Partners Germany GmbH | Investment Managers | Private Equity Investor | |
University of London | College/University | Graduate Degree | |
EXACT THERAPEUTICS | Biotechnology | Chief Executive Officer | |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Private Equity Investor | |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Haas School of Business | College/University | Masters Business Admin | |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Pharmaceuticals: Major | Director/Board Member | |
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
University of Michigan | College/University | Undergraduate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 25 |
Verenigde Staten | 20 |
Duitsland | 3 |
Nederland | 3 |
Denemarken | 3 |
Sectoraal
Health Technology | 22 |
Consumer Services | 10 |
Finance | 9 |
Commercial Services | 6 |
Technology Services | 5 |
Operationeel
Director/Board Member | 90 |
Corporate Officer/Principal | 21 |
Chief Executive Officer | 18 |
Chairman | 17 |
Founder | 15 |
Sterkste connecties
Insiders | |
---|---|
Mike Darcey | 33 |
Geert-Jan Mulder | 17 |
Niall O'Donnell | 17 |
Peter C. M. McWilliams | 17 |
Kenneth Harrison | 13 |
Christopher Starr | 12 |
Andrew Geoffrey Goldwater | 11 |
John W. Ford | 10 |
Jim Trenkle | 10 |
Daniela Couto | 7 |
Jenny Elizabeth Davies | 6 |
Dmitrij Hristodorov | 5 |
Rafiq Hasan | 3 |
Max Klement | 2 |
Ken Harrison | 1 |
- Beurs
- Insiders
- Steven Jon Axon
- Bedrijfsconnecties